> > >

FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs Friday, 13 September 2019 ()
The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled
Credit: Rumble - Published < > Embed
News video: FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs

FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs 00:58

​The FDA says Zantac-brand heartburn medicines contain small amounts of a known &quot;probable carcinogen.&quot;

You Might Like

Recent related news from verified sources

U.S. FDA flags probable cancer-causing impurity in common heartburn drugs

The U.S. Food and Drug Administration said on Friday that some medicines containing ranitidine, including Sanofi SA's Zantac, had traces of a probable...
Reuters India

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest